[New quinolones in urological diseases of an inflammatory nature].
New drugs of the group of the 3rd generation fluoroquinolones i. e. norfloxacin, ciprofloxacin, ofloxacin and pefloxacin possess a high antibacterial activity against the majority of the problem causative agents of urinary infections. This was confirmed by the studies on sensitivity of 950 clinical strains of the pathogens isolated from inpatients of an urological department. Sensitivity of the majority of the pathogens to the fluoroquinolones was the following: 80.3 to 100 per cent among enteric bacteria, 80.2 to 89.6 per cent among Pseudomonas spp. and 94.7 to 100 per cent among Staphylococci, 288 patients were treated with the fluoroquinolones. The patients were divided into 3 groups according to the urinary infection i. e. acute inflammatory diseases, chronic pyelonephritis and chronic inflammatory diseases of the genital tract. The results of the studies estimated by complex clinico-laboratory indices revealed a close efficacy of the drugs in the patients. This was due to their analogous antibacterial spectra and similar pharmacokinetic characteristics investigated in 23 patients after the drug administration by various routes: intravenous and oral. No differences in tolerance of the fluoroquinolones were observed.
Perepanova
T S
TS
Ukhin
A V
AV
Kondrat'eva
E M
EM
Kotliarova
G A
GA
Siniukhin
V N
VN
Derevnianko
I I
II
D000208:Acute Disease; D002908:Chronic Disease; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D008297:Male; D015363:Quinolones / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D015363:Quinolones
Novye khinolony pri urologicheskikh zabolevaniiakh vospalitel'noĭ prirody.